Quantitative detection of cell-free fetal DNA in peripheral blood of pregnant women during early pregnancy

被引:0
|
作者
Qiu, Y. [1 ]
Liu, C. [1 ]
机构
[1] Zigong Matern & Child Care Hosp, Dept Obstet & Gynecol, Zigong 643000, Sichuan, Peoples R China
来源
关键词
Cell-free fetal DNA; SRY gene; Nested PCR; Fluorescence quantitative PCR; Gestational period; MATERNAL PLASMA;
D O I
10.12891/ceog4825.2019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study aimed for the quantitative detection of cell-free fetal DNA (cffDNA) in peripheral plasma of pregnant women, which provides basic data for clinical non-invasive prenatal screening in early pregnancy. Materials and Methods: A total of 243 individuals with gestational age of 5-10(+6) weeks were selected for this study, who required abortion. mDNA was extracted from villi, and Y-chromosome specific SRY gene was detected by nested PCR, which was regarded as standard for quantitative detection of accuracy. CffDNA was extracted from peripheral blood and SRY gene's expression was detected by real-time fluorescent quantitative PCR. Results: Among 243 cases, nested PCR detected 163 individuals with SRY gene positive, and 80 were negative. Out of 163, in 140 cases SRY was detected in cffDNA, but 23 cases with gestational age 5-6 + 6 weeks were negative. However at 7th week of pregnancy, it was also detected in those 23 cases. The average concentration of cff DNA in 10th week of pregnancy was found significantly higher than in 7th, 8th, and 9th week of pregnancy. Conclusion: Thus, this study indicates the efficiency and reliability of cffDNA in peripheral blood of 7-10th week of gestational period for the detection of early pregnancy.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 50 条
  • [41] Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh negative women in turkey
    Elgun, Tugba
    Oltulu, Yasemin Musteri
    Yurttas, Asiye Gok
    Agyuz, Umut
    Molla, Fulya Ozkal
    Kilic, Ulkan
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2023, 30 (03) : 324 - 328
  • [42] Cell-Free Fetal DNA in the Early and Late First Trimester
    Miltoft, Caroline Borregaard
    Rode, Line
    Bundgaard, Jens Rene
    Johansen, Peter
    Tabor, Ann
    FETAL DIAGNOSIS AND THERAPY, 2020, 47 (03) : 228 - 236
  • [43] Association of Fetal Fraction of Cell-Free DNA and Hypertensive Disorders of Pregnancy
    Bender, Whitney R.
    Koelper, Nathanael C.
    Sammel, Mary D.
    Dugoff, Lorraine
    AMERICAN JOURNAL OF PERINATOLOGY, 2019, 36 (03) : 311 - 316
  • [44] Fetal ploidy status in pregnancy loss evaluated by cell-free fetal DNA in maternal blood versus direct sequencing of the pregnancy tissue
    Hartwig, T. Schlaikjaer
    Ambye, L.
    Gruhn, J. R.
    Chan, A. Chi-Ho
    Ji, B.
    Jorgensen, F. S.
    Hoffmann, E. R.
    Nielsen, H. Svarre
    HUMAN REPRODUCTION, 2023, 38
  • [45] Circulating cell-free DNA for cancer early detection
    Gao, Qiang
    Zeng, Qiang
    Wang, Zhijie
    Li, Chengcheng
    Xu, Yu
    Cui, Peng
    Zhu, Xin
    Lu, Huafei
    Wang, Guoqiang
    Cai, Shangli
    Wang, Jie
    Fan, Jia
    INNOVATION, 2022, 3 (04):
  • [46] Preliminary results of fetal RHC examination in cell-free fetal DNA from plasma of pregnant women with anti-C
    Orzinska, A.
    Guz, K.
    Zupanska, B.
    Brojer, E.
    VOX SANGUINIS, 2008, 95 : 209 - 209
  • [47] Methylation in cell-free DNA for early cancer detection
    de la Cruz, F. Fece
    Corcoran, R. B.
    ANNALS OF ONCOLOGY, 2018, 29 (06) : 1351 - 1353
  • [48] Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood
    Sehnert, Amy J.
    Rhees, Brian
    Comstock, David
    de Feo, Eileen
    Heilek, Gabrielle
    Burke, John
    Rava, Richard P.
    CLINICAL CHEMISTRY, 2011, 57 (07) : 1042 - 1049
  • [49] Cell free fetal DNA is detectable in the CSF of some pregnant women
    Angert, RM
    LeShane, ES
    Yarnell, RW
    Bianchi, DW
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 556 - 556
  • [50] Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
    Sundby, R. Taylor
    Szymanski, Jeffrey J.
    Pan, Alexander C.
    Jones, Paul A.
    Mahmood, Sana Z.
    Reid, Olivia H.
    Srihari, Divya
    Armstrong, Amy E.
    Chamberlain, Stacey
    Burgic, Sanita
    Weekley, Kara
    Murray, Bega
    Patel, Sneh
    Qaium, Faridi
    Lucas, Andrea N.
    Fagan, Margaret
    Dufek, Anne
    Meyer, Christian F.
    Collins, Natalie B.
    Pratilas, Christine A.
    Dombi, Eva
    Gross, Andrea M.
    Kim, Aerang
    Chrisinger, John S. A.
    Dehner, Carina A.
    Widemann, Brigitte C.
    Hirbe, Angela C.
    Chaudhuri, Aadel A.
    Shern, Jack F.
    CLINICAL CANCER RESEARCH, 2024, 30 (19) : 4363 - 4376